Episodes

  • From Complex Experiments to Connected Insight
    Nov 20 2026
    Sponsored by Molecular Devices

    Hosted on Acast. See acast.com/privacy for more information.

    Show More Show Less
    34 mins
  • What Are the Cells Trying to Tell Us?
    Nov 20 2026
    Sponsored by Molecular Devices

    Hosted on Acast. See acast.com/privacy for more information.

    Show More Show Less
    18 mins
  • Toward Connected Laboratory Ecosystems
    Nov 13 2026

    These days, many laboratories are eager to apply AI, but the systems and workflows that they have implemented often stand in the way. When systems run separately, information gets trapped in silos and scientific context is lost between steps. Also, manual handoffs slow the work down and introduce risk at various points in lab processes. Connecting those systems and workflows first gives AI the operational and scientific context it needs to deliver value that can be both trusted and scaled.


    In this GEN podcast, the third in a series, LabVantage’s Denise Bell discusses how laboratories can reduce operational fragmentation and build connected, scalable operations. The discussion covers workflow orchestration across laboratory functions, ways to reduce manual handoffs and information silos, and offers some practical starting points for AI adoption. It also looks at how bringing LIMS, ELN, LES, and SDMS together in a unified laboratory execution environment enables workflow intelligence and AI assistance in the right scientific and operational context.


    Speaker: Denise Bell

    Moderator: Uduak Thomas

    Hosted on Acast. See acast.com/privacy for more information.

    Show More Show Less
    26 mins
  • Precision Automation Meets Biology
    Oct 30 2026

    Episode 1: Precision Automation Meets Biology


    Central question: How can automation help scientists move faster without losing sight of the biology?


    This opening episode would introduce precision automation as the connective tissue across the Molecular Devices portfolio. Rather than defining automation simply as higher throughput, we would explore how purpose-built tools help biologists reduce repetitive work, control variability, improve consistency, and focus more of their time on scientific decisions.


    Potential discussion points:

    • What “precision automation” means for a working biologist
    • Why automation should adapt to the science — not force the science into a rigid process
    • Where manual variability enters cell-based research
    • The balance between speed, consistency, flexibility, and scientific control
    • How purpose-built instruments, software, and expertise work together
    • Why researchers may need different solutions at different points in their journey


    Speaker: Matt Stoltz

    Moderator: Uduak Thomas

    Hosted on Acast. See acast.com/privacy for more information.

    Show More Show Less
    42 mins
  • Data Integrity as the Foundation for AI
    Sep 9 2026

    Artificial intelligence is advancing quickly into laboratory operations, which is why thinking about the quality and integrity of the supporting data early on is important. In regulated environments, that means understanding where the data came from, how it changes, and how AI-generated insights or recommendations can be traced, reviewed, trusted, and ultimately defended.


    In this GEN podcast, LabVantage’s Gary Stimson digs into what it takes to build a data foundation for trustworthy AI. The discussion covers concepts like data lineage, traceability, explainability and governance, and the importance of audit-ready laboratory operations. It also looks at the role of intended use, ongoing monitoring, and human review in deploying AI responsibly.

    Hosted on Acast. See acast.com/privacy for more information.

    Show More Show Less
    18 mins
  • Small Molecules, Big Expectations: How CDMOs Are Helping Sponsors Navigate Complexity, Speed, Scale-Up, and Sustainability
    Aug 19 2026

    Small molecules continue to play a major part in pharmaceutical development, but increasing molecular complexity, accelerated timelines, and evolving manufacturing and regulatory requirements are creating new challenges for the industry.


    In this GEN Podcast – part 2 in a 3-part series -- a trio of experts from SK Pharmteco discuss how CDMOs are helping biopharma companies navigate critical areas including scale-up, technology transfer, advanced manufacturing, automation, sustainability, the emergence of AI, and supply chain reliability. The discussion explores practical strategies for improving development efficiency while supporting quality, scalability, and long-term commercial success.


    Guest Speakers

    Steve Barr, PhD -- Head of Small Molecule Business Unit and VP Global Alliances, SK Pharmteco.

    Darryl Ratty -- Executive Director of Global ESG (Environmental, Social and Governance), SK Pharmteco.

    Bill Dubay -- VP, Global Research and Development, SK Pharmteco.


    Moderator:

    Kevin Davies, PhD, Editorial Director, GEN

    Hosted on Acast. See acast.com/privacy for more information.

    Show More Show Less
    34 mins
  • Beyond the Technology: AI Readiness in Regulated Laboratories
    Jul 27 2026

    This episode establishes the broader context for AI adoption. Rather than focusing on AI tools themselves, the discussion explores what laboratories must have in place before AI can be applied responsibly.


    Key discussion areas include:

    • Why fragmented workflows and disconnected systems limit AI effectiveness
    • The importance of trusted, connected laboratory data
    • Human-guided AI and human-in-the-loop governance
    • Why compliance and auditability should be built into AI-enabled workflows from the outset

    Relevant reference to LabVantage CORTEX:


    LabVantage CORTEX embeds AI within laboratory execution workflows so that intelligence operates within existing scientific and compliance processes, rather than as an external layer.

    Hosted on Acast. See acast.com/privacy for more information.

    Show More Show Less
    24 mins
  • Enabling In Vivo Lentiviral Therapies: Manufacturing Strategies to Improve Purity, Scalability, and Clinical Readiness.
    Apr 21 2026

    Lentiviral vectors are gaining momentum not just as ex vivo tools but as potential in vivo therapeutic platforms. But with that shift comes a number of manufacturing challenges, including higher doses, tighter control of impurities, greater batch consistency, and scalable processes to meet both clinical and commercial needs.


    In this GEN Podcast, two experts from SK Pharmteco, a global CMO, address these challenges and lay out some best practices that guide the manufacture of lentiviral vectors with the requisite purity, robustness, and economic feasibility required for widespread clinical adoption.


    Guest speakers:

    Mardhani Aparajithan, Director of Manufacturing, Science and Technology, SK Pharmteco


    Tatiana Nanda, PhD, CTO, Cell and Gene Therapy, SK Pharmteco


    Moderator:

    Kevin Davies, PhD, Editorial Director, GEN

    Hosted on Acast. See acast.com/privacy for more information.

    Show More Show Less
    35 mins